Xueting An
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
BCMA/CD19 CAR T cell therapy for refractory myasthenia gravis: Proteomic signatures and single-cell transcriptomics of disease flares.
Journal: Science advances
Published: January 02, 2026
Real-world efficacy of eculizumab in generalized myasthenia gravis patients with poor early response to efgartigimod: a prospective cohort study.
Journal: Frontiers in immunology
Published: October 23, 2025
Chimeric antigen receptor T cell therapy: a new frontier therapeutic landscape in autoimmune diseases.
Journal: Journal of autoimmunity
Published: June 17, 2025
A real-world comparative study on the efficacy and safety of tocilizumab and rituximab in patients with neuromyelitis optica spectrum disease and myelin oligodendrocyte glycoprotein antibody-associated disease.
Journal: Multiple sclerosis and related disorders
Published: March 14, 2025
NEK2 regulates B cell function and the severity of experimental autoimmune encephalomyelitis.
Journal: Journal of neuroinflammation
Published: March 05, 2025
Serum amyloid A facilitates expansion of CD4+ T cell and CD19+ B cell subsets implicated in the severity of myasthenia gravis patients.
Journal: Journal of neurochemistry
Published: November 05, 2023
Serum neurofilament light chain predicts spinal cord atrophy in neuromyelitis optica spectrum disorder.
Journal: Journal of neuroimmunology
Published: July 19, 2023
Rituximab induces a transient fluctuation of peripheral and follicular helper T cells in neuromyelitis optica spectrum disorder.
Journal: Journal of neuroimmunology
Published: April 19, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026